Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

The role of estrogens in epigenetic regulation of hypoxia-related gene expression in non-small cell lung cancer development

2013/11/B/NZ5/00039

Keywords:

non-small cell lung cancer,estrogens 17β-estradiol epigenetics hypoxia normoxia

Descriptors:

  • NZ5_3: Pathogenesis of human diseases
  • NZ1_1: Molecular biology
  • NZ3_1: Cell biology

Panel:

NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution :

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

woj. wielkopolskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

prof. Paweł Jagodziński 

Number of co-investigators in the project: 10

Call: OPUS 6 - announced on 2013-09-16

Amount awarded: 931 627 PLN

Project start date (Y-m-d): 2014-07-22

Project end date (Y-m-d): 2020-01-21

Project duration:: 66 months (the same as in the proposal)

Project status: Project settled

Equipment purchased [PL]

  1. Inkubator CO2 z płaszczem wodnym Forma* Series II 3110 (70 000 PLN)

Information in the final report

  • Publication in academic press/journals (4)
  • Articles in post-conference publications (1)
  1. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers
    Authors:
    Hanna Drzewiecka, Bartłomiej Gałęcki, Donata Jarmołowska-Jurczyszyn, Andrzej Kluk, Wojciech Dyszkiewicz, Paweł P. Jagodziński
    Academic press:
    Journal of Cancer Research and Clinical Oncology (rok: 2016, tom: 142, strony: 1927-1946), Wydawca: Springer
    Status:
    Published
    DOI:
    10.1007/s00432-016-2195-3 - link to the publication
  2. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer
    Authors:
    Drzewiecka H, Gałęcki B, Jarmołowska-Jurczyszyn D, Kluk A, Dyszkiewicz W, Jagodziński PP
    Academic press:
    Lung Cancer (rok: 2015, tom: 87, strony: 107-116), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.lungcan.2014.12.012 - link to the publication
  3. Increased expression of proline-, glutamic acid- and leucine-rich protein PELP1 in non-small cell lung cancer
    Authors:
    Słowikowski BK, Gałęcki B, Dyszkiewicz W, Jagodziński PP
    Academic press:
    Biomedicine & Pharmacotherapy (rok: 2015, tom: 73, strony: 97-101), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.biopha.2015.05.015 - link to the publication
  4. Altered expression of 17-beta-hydroxysteroid dehydrogenase type 2 and its prognostic significance in non-small cell lung cancer
    Authors:
    Hanna Drzewiecka, Donata Jarmołowska-Jurczyszyn, Andrzej Kluk, Bartłomiej Gałęcki, Wojciech Dyszkiewicz, Paweł P. Jagodziński
    Academic press:
    International Journal of Oncology (rok: 2020, tom: 56, strony: 1352-1372), Wydawca: Spandidos Publications
    Status:
    Published
    DOI:
    10.3892/ijo.2020.5014 - link to the publication
  1. Expression of 17-beta-hydroxysteroid dehydrogenase type 1 and type 2 in non-small cell lung cancer
    Authors:
    Hanna Drzewiecka, Bartłomiej Gałęcki, Wojciech Dyszkiewicz, Paweł P. Jagodziński.
    Conference:
    26th Bilateral Symposium Poznan-Halle "From Molecular Medicine to Public Health - Translational Research in Cardiovascular Medicine and Oncology" (rok: 2015, ), Wydawca: MARTIN LUTHER UNIVERSITY HALLE−WITTENBERG
    Data:
    konferencja 23-25 październik
    Status:
    Published

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy